Bhadhuri, A.; Insinga, R.; Guggisberg, P.; Panje, C.; Schwenkglenks, M. Cost Effectiveness of Pembrolizumab Vs Chemotherapy As First-Line Treatment for Metastatic NSCLC That Expresses High Levels of PD-L1 in Switzerland. Swiss Med Wkly 2019, 149, w20170.